Skip to search.
 TSX Down 0.60% TSX Ventures Down 1.08%

Geron Corporation (GERN)

-NasdaqGS
4.32 Up 0.17(4.10%) Jul 6, 4:00PM EDT
|After Hours : 4.32 0.00 (0.00%) Jul 6, 4:20PM EDT
Add to Portfolio
Prev Close:4.15
Open:4.10
Bid:4.18 x 3000
Ask:4.37 x 4000
1y Target Est:5.50
Beta:1.92
Next Earnings Date:N/A
Day's Range:4.05 - 4.35
52wk Range:1.76 - 4.67
Volume:2,714,189
Avg Vol (3m):2,474,940
Market Cap:682.94M
P/E (ttm):N/A
EPS (ttm):-0.23
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GERNUp 4.10%682.94M
BMYUp 0.03%112.52B
GSKDown 0.73%101.31B
NVSDown 1.18%238.69B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):539.52
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.07
Quarterly EPS Est (Jun-15) :-0.06
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):-11.60

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Geron Corporation, a clinical stage biopharmaceutical company, focuses on the development of telomerase inhibitor, imetelstat, for treating hematologic myeloid malignancies. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback